featured
Individualised, Short-Course Antibiotic vs Usual Long-Course Treatment for Patients With Ventilator-Associated Pneumonia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial
Lancet Respir Med 2024 Jan 22;[EPub Ahead of Print], Y Mo, S Booraphun, AY Li, P Domthong, G Kayastha, YH Lau, P Chetchotisakd, D Limmathurotsakul, PA Tambyah, BS CooperFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.